Tenofovir - CISMeF

Preferred Label : Tenofovir;

MeSH definition : An adenine analog REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B. It is used to treat HIV INFECTIONS and CHRONIC HEPATITIS B, in combination with other ANTIVIRAL AGENTS, due to the emergence of ANTIVIRAL DRUG RESISTANCE when it is used alone.;

MeSH synonym : 9-PMPA (tenofovir); 9-(2-Phosphonylmethoxypropyl)adenine; 9-(2-Phosphonomethoxypropyl)adenine;

DeCS synonym : Tenofovir Disoproxil;

MeSH hyponym : 9-(2-phosphonylmethoxypropyl)adenine, (S)-isomer; tenofovir disoproxil fumarate; 9-(2-phosphonylmethoxypropyl)adenine, ( -)-isomer; viread; 9-(2-Phosphonylmethoxypropyl)adenine, (R)-isomer - T357098; Disoproxil Fumarate, Tenofovir; Fumarate, Tenofovir Disoproxil; Disoproxil, Tenofovir; (R)-9-(2-phosphonylmethoxypropyl)adenine;

CISMeF hyponym : Tenofovir Disoproxil;

MeSH Related Number : 121149-89-1 (( -)-isomer); 147127-19-3 ((S)-isomer); 147127-20-6 ((R)-isomer); OTT9J7900I; F4YU4LON7I;

Wikipedia link : https://en.wikipedia.org/wiki/Tenofovir disoproxil;

Is substance : O;

UNII : 99YXE507IL;

Details

Origin ID

D000068698;

UMLS CUI

C0384228;

ATC code(s)
- emtricitabine, tenofovir disoproxil and efavirenz [ATC Code]
ATC code(s)
- lamivudine and tenofovir disoproxil [ATC Code]
- lamivudine, tenofovir disoproxil and doravirine [ATC Code]
- lamivudine, tenofovir disoproxil and efavirenz [ATC Code]
- tenofovir disoproxil [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Tenofovir [NCIt concept]
- Tenofovir disoproxil (substance) [SNOMED CT concept]
Pharmacological action(s)
- anti-hiv agents [MeSH Descriptor]
- reverse transcriptase inhibitors [MeSH Descriptor]
Record concept(s)
- 9-(2-Phosphonylmethoxypropyl)adenine, (R)-isomer - T357098 [MeSH concept]
- 9-(2-phosphonylmethoxypropyl)adenine, (+-)-isomer [MeSH concept]
- 9-(2-phosphonylmethoxypropyl)adenine, (S)-isomer [MeSH concept]
- Tenofovir Disoproxil [MeSH concept]
- tenofovir [MeSH concept]
- tenofovir disoproxil fumarate [MeSH concept]
- viread [MeSH concept]
Related MeSH Supplementary Concept(s)
- bictegravir, emtricitabine, tenofovir alafenamide, drug combination [MeSH Supplementary Concept]
- efavirenz, lamivudine, tenofovir disoproxil fumarate drug combination [MeSH Supplementary Concept]
- emtricitabine tenofovir alafenamide [MeSH Supplementary Concept]
- lamivudine, tenofovir disoproxil fumarate drug combination [MeSH Supplementary Concept]
- symtuza [MeSH Supplementary Concept]
- tenofovir alafenamide [MeSH Supplementary Concept]
Semantic type(s)
- Nucleic Acid, Nucleoside, or Nucleotide [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing tenofovir (medicinal product) [SNOMED CT concept]
- Tenofovir [LOINC component]
- Tenofovir [NCIt concept]
- Tenofovir (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients